Comparative in-vitro activity of quinupristin/dalfopristin (RP 59500) tested against penicillin- and macrolide-resistant pneumococci by the Etest

被引：4

作者：

Biedenbach, D ^{[1
]}

Wanger, A ^{[1
]}

Jones, RN ^{[1
]}

机构：

[1] UNIV TEXAS,HLTH SCI CTR,DEPT PATHOL,HOUSTON,TX

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1996年 / 38卷 / 03期

关键词：

D O I：

10.1093/jac/38.3.553

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：553 / 555

页数：3

共 6 条

[1] PREVALENCE OF MACROLIDES-LINCOSAMIDES-STREPTOGRAMIN-B RESISTANCE AND ERM GENE CLASSES AMONG CLINICAL STRAINS OF STAPHYLOCOCCI AND STREPTOCOCCI [J].

JENSSEN, WD ;

THAKKERVARIA, S ;

DUBIN, DT ;

WEINSTEIN, MP .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (06) :883-888

[2] IN-VITRO ACTIVITY OF RP-59500 (QUINUPRISTIN DALFOPRISTIN) AGAINST ANTIBIOTIC-RESISTANT STRAINS OF STREPTOCOCCUS-PNEUMONIAE AND ENTEROCOCCI [J].

JOHNSON, CC ;

SLAVOSKI, L ;

SCHWARTZ, M ;

MAY, P ;

PITSAKIS, PG ;

SHUR, AL ;

LEVISON, ME .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 21 (03) :169-173

[3] RP-59500 PROPHYLAXIS OF EXPERIMENTAL ENDOCARDITIS DUE TO ERYTHROMYCIN-SUSCEPTIBLE AND ERYTHROMYCIN-RESISTANT ISOGENIC PAIRS OF VIRIDANS GROUP STREPTOCOCCI [J].

LHERITEAU, F ;

ENTENZA, JM ;

LACASSIN, F ;

LEPORT, C ;

GLAUSER, MP ;

MOREILLON, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) :1425-1429

[4] INFECTIONS CAUSED BY STREPTOCOCCUS-PNEUMONIAE - CLINICAL SPECTRUM, PATHOGENESIS, IMMUNITY, AND TREATMENT [J].

MUSHER, DM .

CLINICAL INFECTIOUS DISEASES, 1992, 14 (04) :801-809

[5]

*NAT COMM CLIN LAB, 1995, PERF SAND ANT SUSC T

[6] OCCURRENCE OF MACROLIDE LINCOSAMIDE STREPTOGRAMIN RESISTANCES AMONG STAPHYLOCOCCAL CLINICAL ISOLATES AT A UNIVERSITY MEDICAL-CENTER - IS FALSE SUSCEPTIBILITY TO NEW MACROLIDES AND CLINDAMYCIN A CONTEMPORARY CLINICAL AND INVITRO TESTING PROBLEM [J].

SANCHEZ, ML ;

FLINT, KK ;

JONES, RN .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1993, 16 (03) :205-213

← 1 →